A PhD scientist with an MBA from the University of Connecticut, Sarah is the Director of GU Oncology Medical Affairs at Eli Lilly and Company. She has extensive experience in both academic and industry settings, with a career at Lilly that has progressed through various medical affairs roles, including early-phase and pipeline strategy.
Her doctoral research focused on the defensive secondary metabolism of Pseudonocardia symbionts found in fungus-growing ants.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.